Page 86 - Evelop News Today

The Central government has planned to collaborate with the Arunachal Pradesh government to develop a district good governance portal for monitoring the performance of each district of the state on a monthly basis and help in benchmarking performance.

BEIJING, Aug. 17 (Xinhua) -- Li Zhanshu, chairman of the National People Congress (NPC) Standing Committee, on Wednesday met with Tonga Speaker of the Legislati

Rokiah Mahmud His Royal Highness Prince (Dr) Haji Al-Muhtadee Billah ibni His Majesty Sultan Haji Hassanal Bolkiah Mu’izzaddin Waddaulah, the Crown Prince and Senior Minister at the Prime Minister’s Office in a sabda yesterday called on the need to broaden and develop the teaching of Al-Quran memorisation techniques as there is growing number of people […]

Experts at the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, a hub focused on drug discovery for neglected tropical diseases, are aiming to develop a new treatment for Chagas disease. Click to read more...

Researchers have developed a contact lens that can catch and identify exosomes, nanometer-sized vesicles prevalent in human fluids that have the potential to be diagnostic cancer biomarkers.

- Just – Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus... | August 10, 2022

Minister for Further and Higher Education, Research, Innovation and Science Simon Harris TD has today launched a €65 million fund to drive solutions to the green transition and to digital transformation

It is commonly known that bats utilise ultrasonic sounds to orient themselves and use the echoes that follow to create an impression of their environment

Audio Weaver® an Audio SW Development Platform, an Audio drag and drop EDA suite if you like, to streamline the audio algorithm SW development process ...

Collaboration expands to include development of monospecific antibody candidates to address malignant solid tumors Expanded collaboration leverages Genmab's proprietary HexaBody technology platform